HSPD1P5

Across TCGA pan-cancer cohorts, HSPD1P5 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated HSPD1P5 data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher HSPD1P5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HSPD1P5 expression acts as an unfavorable survival marker, although some lineages such as READ and KIRC show a favorable association.

LIHC, KIRP, and ACC are the cancer types where HSPD1P5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Quartile	III,IV	0.361	0.741	.001	66	view →
KIRP	OS	Quartile	All	0.535	0.897	<.001	54	view →
ACC	DFS	Median	All	0.252	0.616	<.001	46	view →
READ	DFS	Median	All	0.895	0.739	.010	24	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	24	view →
KIRC	DFS	Median	III,IV	0.585	0.319	.011	22	view →
OV	OS	Quartile	II,III,IV	0.350	0.247	.021	22	view →
SARC	OS	Median	All	0.766	0.937	.005	18	view →
GBM	DFS	Tertile	All	0.413	0.155	.003	15	view →
STAD	DFS	Tertile	III,IV	0.418	0.679	.003	15	view →
DLBC	DFS	Median	IV	0.128	1.000	.017	14	view →
THCA	DFS	Median	III,IV	0.874	0.246	.002	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 25 lineages.

HSPD1P5–LIHC (OS)

Open the LIHC breakdown →